MY ACCOUNT | NEWSLETTER |

VMX 2023: Neogen talks affordable, effective Provecta flea, tick treatment

Company unveils Provecta Cares Initiative to support pet parents, veterinary teams


At the recent VMX convention in Orlando, Veterinary33 spoke with team members from Neogen, which provides a variety of products for all veterinary practices, from small animals to large. The company’s solutions support veterinarians and their clients for wound care, prescriptions and genetic testing. 

Neogen also helps to prevent the spread of pathogens and diseases among patients and teams with cleaners, disinfectants and sanitation solutions specifically formulated for use in animal environments.

At VMX, Leslie Cash, vice president of commercial pet healthcare at Neogen, highlighted Provecta Advanced, which repels and kills ticks, fleas and mosquitos and effectively breaks the flea lifecycle. The product is easy to apply, waterproof and fragrance-free. It also contains the active ingredients imidacloprid and pyriproxyfen.

It can be used with dogs and cats, and the price point is affordable – according to Neogen promotional materials, the cost is $3.74 per dose for Provecta II for cats, with one dose per month. For Provecta Advanced for Dogs, the cost is $4.49 per dose and is also applied monthly. The products are available through veterinarians. 

Cash said that given the current economic situation in the U.S., the company recently conducted a pet owner survey and talked with consumers about inflation. 

“Nearly 80% of pet parents in the U.S. are impacted by inflation right now,” she said. “They’ve signaled that this will change some of their behaviors. As a manufacturer, we want to make sure they have solutions that are efficacious and affordable.”

Provecta is less expensive than oral flea and tick treatments, said Cash. 

“It’s great for pets that need the added benefit of repellency, and the product also kills eggs and larvae,” she said. “We want to make sure pet parents are caring for their pets and can afford to do that during these times of inflation. In our recent study, as we dove deeper into impacts, we found that nearly 30% of pet owners said they were going to have to make different choices in the products they purchase for their pets in flea and tick treatments.” 

Cash and her colleagues also highlighted Provecta Cares, which was unveiled at VMX 2023. This new program helps pet owners by offering more affordable pet treatments. The initiative also supports veterinarians by giving them products that are affordable and don’t have huge inventory requirements. 

As part of the new program Neogen will initially contribute $10,000 to the Veterinary Hope Foundation to support veterinarians as they navigate common stressors unique to their profession.

“We’ve started a partnership with the Veterinary Hope Foundation that is particularly important now,” said Cash. “Veterinarians, vet techs and nurses are all under pressure at work. We are committed to supporting the foundation’s efforts to bring resources and care to the vet community and for people that may be struggling. The mental health crisis is amplified in veterinary medicine. We are stepping up for clinicians and staff that need that support.”

Learn more about Provecta at: https://provectapet.com/

For access to mental health resources and support unique to the veterinary community, visit https://veterinaryhope.org/

This story was produced by Mary Guiden and Alexandra Koffler. 

Like3
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top